The High Court has dismissed a case by a law firm client who claimed he was entitled under the law of restitution to $1.4 million in interest on a $900,000 sum his lawyers repaid in a fight about legal fees.
The parties in a class action against agricultural giant GrainCorp over alleged noise and odour pollution from a factory in rural Victoria have failed to seal the deal on a settlement reached last month.
ASIC is considering an appeal of a ruling that tossed its conflicted remuneration case against Freedom Insurance’s former boss and another executive over a sales incentive scheme.
Law firm Gillis Delaney has defeated a bid for third-party costs by a warehouse management software company that was named in an intellectual property dispute, with a judge rejecting claims the firm was not authorised to act and acted unreasonably.
The tax commissioner has suffered a major loss in a dispute with Malaysian power company YTL Power over a $948 million capital gain from the sale of its stake in South Australia-based ElectraNet in 2022.
An adjudicator’s decision awarding $10 million to a builder on Queensland developer Heran Group’s high-rise luxury apartment building in Main Beach lacked procedural fairness after he went outside the parties’ submissions, a judge has found.
A builder has lost an appeal arguing that a RW Capital unit was bound by an alleged contract to develop land in northern Sydney, said to be worth $25.75 million, after the trial judge found the claim was “doomed to fail”.
The lead plaintiffs in a lawsuit against Transport for New South Wales over the compulsory acquisition of land for the WestConnex road project have won their bid to toss a third suit brought by the funder which backed the case.
A class action law firm is set to file a representative complaint against fertility services provider Genea over a data breach that led to sensitive patient information being published on the dark web.
Suspecting infringement of patents for its Parkinson’s drug, Xadago, biopharmaceutical company Newron has won preliminary discovery of documents from generic drug maker Arrotex Pharmaceuticals.